Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155205 · ClinicalTrials.gov registry record · Phase 1
A Thorough QT Study of Telotristat Etiprate
A Phase 1 study, sponsored by Lexicon Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT02155205 is a Phase 1 study that has completed, run by Lexicon Pharmaceuticals. The registered enrollment target is 48 participants.
The verdict
NCT02155205, a Phase 1 study, has completed, sponsored by Lexicon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that telotristat etiprate does not differ from placebo in the mean change from Baseline QT interval corrected for heart rate.
Interventions
- DRUG Placebo
- DRUG Moxifloxacin
- DRUG Telotristat etiprate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155205
The ClinicalTrials.gov registry entry for NCT02155205 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lexicon Pharmaceuticals, which has 56 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02155205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155205 about?
NCT02155205 is a clinical study titled "A Thorough QT Study of Telotristat Etiprate". The purpose of this study is to demonstrate that telotristat etiprate does not differ from placebo in the mean change from Baseline QT interval corrected for heart rate.
What is the current status of trial NCT02155205?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2014-05.
What interventions are being tested in trial NCT02155205?
The interventions under investigation include: Placebo (DRUG), Moxifloxacin (DRUG), Telotristat etiprate (DRUG).
Who is sponsoring clinical trial NCT02155205?
This trial is sponsored by Lexicon Pharmaceuticals, which has 56 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.